Brind.

DZ Bank upgraded AbbVie shares to strong-buy, and Morgan Stanley upgraded the price target on AbbVie stock.

10 reports, 3 independent Updated Oct 8
Gone quiet Reached 2 outlets in its first 24 hours
Reports
10
Developments
3
Repetition
70%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

DZ Bank upgraded AbbVie shares to strong-buy, and Morgan Stanley upgraded the price target on AbbVie stock.

Who's involved

What this event is mainly about
AbbVieDZ BankMorgan Stanley

How it developed

Newest first. Tap a step to see who reported it.
  1. DZ Bank and Morgan Stanley upgraded AbbVie, while MarketBeat provided consensus rating data.1 source
  2. Morgan Stanley raised price objective on AbbVie; DZ Bank upgraded stock rating.1 source
  3. AbbVie received buy ratings and price target increases from DZ Bank and Morgan Stanley.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
3 more outlets ran the same wire story